Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging
- 171 Downloads
The sympathetic nervous system provides an important trigger for major arrhythmic events through regional heterogeneity of sympathetic activity, which could be evaluated by SPECT imaging as the regional MIBG washout rate (WR). There is little information available on the prognostic value of regional WR in SPECT imaging for the prediction of sudden cardiac death (SCD) in patients with chronic heart failure (CHF).
We studied 73 CHF outpatients with LVEF < 40%. At study entry, the regional WR was measured in 17 segments on the polar map. We defined abnormal regional WR as both the regional WR range (maximum − minimum regional WR) and maximum regional WR > mean value + 2SD obtained in 15 normal controls.
During a mean follow-up of 7.5 ± 4.1 years, 15 of 73 patients had SCD. The abnormal regional WR and abnormal global WR on planar images were significantly and independently associated with SCD. Patients with both the abnormal regional WR and global WR had a significantly higher risk of SCD than those with none of these criteria.
The analysis of regional MIBG WR on SPECT imaging provides additional prognostic value to global WR on planar images for SCD prediction in CHF patients.
KeywordsMIBG imaging heart failure SPECT
Single-photon emission computed tomography
Sudden cardiac death
Chronic heart failure
Left ventricular ejection fraction
Implantable cardioverter defibrillator
Summed extent score
Summed severity score
No financial or other relationships that could lead to a conflict of interest are associated with this study.
- 4.Merlet P, Valette H, Dubois-Randé JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471–7.Google Scholar
- 5.Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study. J Am Coll Cardiol. 2003;41:231–8.CrossRefGoogle Scholar
- 7.Tamaki S, Yamada T, Okumura Y, Motita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol. 2009;53:426–35.CrossRefGoogle Scholar
- 12.Kawai T, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, et al. Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction < 35% at low risk of sudden cardiac death. Am J Cardiol. 2015;115:1549–54.CrossRefGoogle Scholar
- 13.Hakui H, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, et al. Usefulness of cardiac metaiodobenzylguanidine imaging to improve prognostic power of the model for end-stage liver disease scoring system in patients with mild-to-moderate chronic heart failure. Am J Cardiol. 2016;117:1947–52.CrossRefGoogle Scholar
- 16.Clements IP, Garcia EV, Chen J, Folks RD, Butler J, Jacobson AF. Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99 m tetrofosmin myocardial perfusion SPECT. J Nucl Cardiol. 2016;23:425–35.CrossRefGoogle Scholar
- 19.Fukuoka S, Hayashida K, Hirose Y, Shimotsu Y, Ishida Y, Kakuchi H, et al. Use of 123I-MIBG myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy. Eur J Nucl Med. 1997;24:523–9.Google Scholar
- 27.Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769–77.CrossRefGoogle Scholar
- 29.McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847.CrossRefGoogle Scholar
- 30.Pretorius H, Menke D, Richards N, Budke B. Modified fractal analysis of brain PET and SPECT defines three distinct cognitive groups in medical office patients: Near normal, mild cognitive impairment and early dementia. J Nucl Med. 2014;55:1851.Google Scholar